Innogest, Panakès lead €4.2m series-A for Seventeen

As part of the deal, the GPs will add several representatives from the Italian oncology sector to the company's board, including Massimo Romanelli, former oncology division manager at AngioDynamics; Lucio Fumi, former director at Interventional Oncology BTG; and Gentium co-founder and former CEO Laura Iris Ferro.

The company aims to use the fresh capital to boost its product's development phase as well as to reach its clinical validation.

Company
Based in Naples, Seventeen operates it the interventional oncology sector It has developed a radioactive gel focused on the treatment of non-operable tumours.

People
Innogest – Claudio Rumazza (partner).
Panakès Partners – Diana Saraceni (co-founder, general partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• Healthcare
• Southern Europe
• Italy